227 related articles for article (PubMed ID: 12680799)
21. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons.
Müller L; Saydam O; Saeki Y; Heid I; Fraefel C
J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700
[TBL] [Abstract][Full Text] [Related]
22. Functionally distinct subpopulations of cord blood CD34+ cells are transduced by adenoviral vectors with serotype 5 or 35 tropism.
Nilsson M; Karlsson S; Fan X
Mol Ther; 2004 Mar; 9(3):377-88. PubMed ID: 15006604
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.
Teschendorf C; Warrington KH; Siemann DW; Muzyczka N
Anticancer Res; 2002; 22(6A):3325-30. PubMed ID: 12530082
[TBL] [Abstract][Full Text] [Related]
24. High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch.
Gaillet B; Gilbert R; Amziani R; Guilbault C; Gadoury C; Caron AW; Mullick A; Garnier A; Massie B
Biotechnol Prog; 2007; 23(1):200-9. PubMed ID: 17269689
[TBL] [Abstract][Full Text] [Related]
25. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
26. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
[TBL] [Abstract][Full Text] [Related]
27. Efficient ectopic gene expression targeting chick mesoderm.
Oberg KC; Pira CU; Revelli JP; Ratz B; Aguilar-Cordova E; Eichele G
Dev Dyn; 2002 Jul; 224(3):291-302. PubMed ID: 12112459
[TBL] [Abstract][Full Text] [Related]
28. Activation of cancer-specific gene expression by the survivin promoter.
Bao R; Connolly DC; Murphy M; Green J; Weinstein JK; Pisarcik DA; Hamilton TC
J Natl Cancer Inst; 2002 Apr; 94(7):522-8. PubMed ID: 11929953
[TBL] [Abstract][Full Text] [Related]
29. A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity.
Kirby TO; Rivera A; Rein D; Wang M; Ulasov I; Breidenbach M; Kataram M; Contreras JL; Krumdieck C; Yamamoto M; Rots MG; Haisma HJ; Alvarez RD; Mahasreshti PJ; Curiel DT
Clin Cancer Res; 2004 Dec; 10(24):8697-703. PubMed ID: 15623655
[TBL] [Abstract][Full Text] [Related]
30. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications.
Paquin A; Jaalouk DE; Galipeau J
Hum Gene Ther; 2001 Jan; 12(1):13-23. PubMed ID: 11177538
[TBL] [Abstract][Full Text] [Related]
31. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
[TBL] [Abstract][Full Text] [Related]
32. Combined use of adenoviral vector Ad5/F35-mediated APE1 siRNA enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in hepatoma cells in vitro and in vivo.
Cun Y; Zhang Q; Xiong C; Li M; Dai N; Zhang S; Wang D
Oncol Rep; 2013 Jun; 29(6):2197-204. PubMed ID: 23563597
[TBL] [Abstract][Full Text] [Related]
33. The cyan fluorescent protein nude mouse as a host for multicolor-coded imaging models of primary and metastatic tumor microenvironments.
Suetsugu A; Hassanein MK; Reynoso J; Osawa Y; Nagaki M; Moriwaki H; Saji S; Bouvet M; Hoffman RM
Anticancer Res; 2012 Jan; 32(1):31-8. PubMed ID: 22213285
[TBL] [Abstract][Full Text] [Related]
34. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.
Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
Int J Oncol; 2008 Dec; 33(6):1141-7. PubMed ID: 19020746
[TBL] [Abstract][Full Text] [Related]
35. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
36. Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft.
Huang X; Lin T; Gu J; Zhang L; Roth JA; Stephens LC; Yu Y; Liu J; Fang B
Gene Ther; 2002 Oct; 9(20):1379-86. PubMed ID: 12365003
[TBL] [Abstract][Full Text] [Related]
37. Stent-mediated gene delivery for site-specific transgene administration to the airway epithelium and management of tracheobronchial tumors.
Kruklitis RJ; Fishbein I; Singhal S; Kapoor V; Levy RJ; Alferiev IS; Sterman DH
Respiration; 2014; 88(5):406-17. PubMed ID: 25323160
[TBL] [Abstract][Full Text] [Related]
38. Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice.
Funovics MA; Weissleder R; Mahmood U
Radiology; 2004 Jun; 231(3):659-66. PubMed ID: 15163807
[TBL] [Abstract][Full Text] [Related]
39. Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer xenografts.
Zhang M; Li S; Li J; Ensminger WD; Lawrence TS
Mol Ther; 2003 Jul; 8(1):21-8. PubMed ID: 12842425
[TBL] [Abstract][Full Text] [Related]
40. Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy.
Wu H; Han T; Lam JT; Leath CA; Dmitriev I; Kashentseva E; Barnes MN; Alvarez RD; Curiel DT
Gene Ther; 2004 May; 11(10):874-8. PubMed ID: 14999229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
